| 【Company Research】Tencent (700 HK) – Eye-catching 1Q20 with strong game & social ads |
| 【公司研究】大家樂 (341 HK) – 憧憬巨額的抗疫補貼以及客流回升 |
| 【公司研究】諾誠健華 (9969 HK) – 專注腫瘤和自免疫領域全球創新藥的生物制藥公司 |
| 【Sector Research】China Brokerage Sector – Reform acceleration could drive further divergence |
| 【行業研究】中國工程機械行業 – 挖掘機4月銷售同比大增60%;5、6月料勢頭持續 |
| 【Company Research】Hong Kong Exchange & Clearing (388 HK) – 1Q20 solid core revenue weighed by invt. losses |
| 【Company Research】JOYY Inc. (YY US) – Expecting solid 1Q20E on track |
| 【公司研究】美的集團 (000333 CH) – 國內復蘇足以抵禦海外訂單損失 |
| 【Company Research】Ascentage Pharma (6855 HK) – HQP-1351 obtained ODD from US FDA |
| 【Sector Research】China Technology Sector – Apple FY2Q above; Conservative outlook as expected |